The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesCannabinoids as therapeutic agents in cancer: current status and future implicationsThe neurobiology of cancer pain.Cannabinoids attenuate cancer pain and proliferation in a mouse modelIncreasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor painThe endocannabinoid system and cancer: therapeutic implication.The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applicationsEffects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in ratsCannabinoid modulation of cutaneous Adelta nociceptors during inflammation.The analgesic potential of cannabinoids.A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painThe non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer painEmerging strategies for exploiting cannabinoid receptor agonists as medicines.Is there any clinically relevant cannabinoid-induced analgesia?Dynamic changes to the endocannabinoid system in models of chronic pain.Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic PainSynergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.
P2860
Q24623282-D825FEB5-0BB1-4CBD-B954-538DC3C3BB22Q26866298-2BB87AE3-122B-4F57-95BF-8D6A037C8980Q34167635-FA4C5B6F-B2BC-49ED-AD0D-A6C9C6B27E5BQ34997343-46EF6614-60B1-431F-B2C4-54823FDDF4BBQ35013497-6403D02C-290B-40D1-AF3A-7306E64599D5Q35162945-E0569BE0-80C9-435A-B523-BFF95A260BC0Q35193299-7FC2DE80-8B4D-4EBD-8BB7-2EB208C7C82AQ35921090-BB77EA0F-3375-4A5E-A757-42BA27DE4450Q36626501-ACCD83D1-C753-4F32-AE6F-F512D70F81C8Q36978586-7ECFD11F-6A9C-4D23-907A-DBE74ECE432FQ37057325-46F7712F-DFD6-41F9-B63F-FEFB4AE4C331Q37067266-FD1A03B4-EE80-4A52-B241-0C2118647280Q37120771-43BBB65C-2B5D-415B-9A31-E8A80C2E72FAQ37230665-A1961AB1-A23B-44E6-BC7F-70029FCF425DQ38003023-575BBE2D-BE4E-434E-8C22-B6CB5256CBAEQ38056398-BDD03A66-9DA4-4554-B995-93F95FAA9069Q38212376-EBF5C008-E39F-4F59-B162-6B45D426B32FQ38754299-A63269E5-EECD-4E3A-8DDF-8E61A9193FEFQ39150711-FB1449BF-934B-4304-A727-234E2A974826Q39727048-E4C28F34-1D1C-475A-98EB-A750064941E4Q53692390-4E8C9D31-DFA1-4871-B5C4-8536DC8F21EB
P2860
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cannabinoid receptor agoni ...... through peripheral mechanisms
@en
The cannabinoid receptor agoni ...... through peripheral mechanisms.
@nl
type
label
The cannabinoid receptor agoni ...... through peripheral mechanisms
@en
The cannabinoid receptor agoni ...... through peripheral mechanisms.
@nl
prefLabel
The cannabinoid receptor agoni ...... through peripheral mechanisms
@en
The cannabinoid receptor agoni ...... through peripheral mechanisms.
@nl
P2093
P2860
P921
P1433
P1476
The cannabinoid receptor agoni ...... through peripheral mechanisms
@en
P2093
Carl Potenzieri
Catherine Harding-Rose
Donald A Simone
P2860
P356
10.1016/J.BRAINRES.2008.03.063
P407
P577
2008-04-06T00:00:00Z